The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kasparova Evg A.

Research Institute of Eye Diseases, 11 A, B Rossolimo St., Moscow, Russian Federation, 119021

Purulent corneal ulcers: clinical presentation, diagnosis, and conservative treatment

Authors:

Kasparova Evg A.

More about the authors

Journal: Russian Annals of Ophthalmology. 2015;131(6): 106‑121

DOI: 10.17116/oftalma20151316106-119

Read: 7567 times

Download PDF (RU)
Contact the author
Table of contents

PURULENT CORNEAL ULCERS: CLINICAL PRESENTATION, DIAGNOSIS, AND CONSERVATIVE TREATMENT
PURULENT CORNEAL ULCERS: CLINICAL PRESENTATION, DIAGNOSIS, AND CONSERVATIVE TREATMENT

To cite this article:

Kasparova Evg A. Purulent corneal ulcers: clinical presentation, diagnosis, and conservative treatment. Russian Annals of Ophthalmology. 2015;131(6):106‑121. (In Russ.)
https://doi.org/10.17116/oftalma20151316106-119

Подписка 2025-2 (Russian Annals of Ophthalmology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Mediasphera_Net
Close metadata
Recommended articles:
Puru­lent scle­ritis following pene­trating kera­toplasty for acanthamoeba kera­titis. Russian Annals of Ophthalmology. 2024;(4):74-79
Perspective dire­ctions in the treatment of poly­cystic ovary syndrome (literature review). Russian Journal of Human Reproduction. 2024;(3):94-104
Differential diagnosis of coccidioidomycosis mani­fested by peri­pheral pulmonary lesion. Piro­gov Russian Journal of Surgery. 2024;(8):77-85
Compression elastography as a new method of ultrasound imaging in the differential diagnosis of chro­nic tonsillitis. Russian Bulletin of Otorhinolaryngology. 2024;(4):20-25
Modern pathogenetic treatment of rare demye­linating diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):33-36
The central vein sign in the differential diagnosis of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):58-65
Mistakes in the diagnosis of neuromyelitis optic spectrum diseases lead to wrong therapy and dete­rioration of patients’ condition. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):96-100
An exte­nsive form of idiopathic atro­phoderma of Pasini and Pierini in a 17-year-old patient. Case report. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(4):422-428
Pathogenetic aspe­cts of chro­nic pelvic pain in endo­metriosis: diagnostic prospects (literature review). Russian Journal of Human Reproduction. 2024;(4):112-120
Rare forms of auto­somal rece­ssive spinocerebellar ataxia asso­ciated with muta­tions in the ANO10 (ATX-ANO10) and SYNE1 (ATX-SYNE1) genes. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8):32-38

This is a detailed review of purulent corneal ulcer signs and symptoms, problems in diagnosis, and conservative treatment options.

Keywords:

purulent corneal ulcer
clinical presentation
diagnosis
treatment
purulent keratitis
bacterial keratitis
fungal keratitis
acanthamoeba keratitis
mixed infections

Authors:

Kasparova Evg A.

Research Institute of Eye Diseases, 11 A, B Rossolimo St., Moscow, Russian Federation, 119021

List of references:

  1. Disorders of eyelids, conjunctiva, lacrimal organs, the cornea and sclera. Multi-volume guide to eye diseases [in 5 vol.]. V Arkhangel'skii, ed. Medgiz; 1960:217-224. (In Russ.)
  2. Maichuk Yu. Choice and dosage of antibiotics for bacterial corneal ulcers. Oftal'mologicheskii zhurnal. 1990;8:502-506. (In Russ.)
  3. Stepanov V, Malov V, Glazunova N. Complex approach to the treatment of purulent lesions of the cornea. Vestnik Orenbeugskogo gosudarstvennogo universiteta. 2004;S:111-113. (In Russ.)
  4. Scott IU, Flynn HW, Feuer W, Pflugfelder SC, Alfonso EC, Forster RK, Miller D. Endophthalmitis associated with microbial keratitis. Ophthalmology. 1996;103(11):1864-1870. doi:10.1016/s0161-6420(96)30415-6
  5. Avetisov S, Kasparov A, Kasparova E, Yusef N. Causes, clinical features, principles and results of urgent keratoplasty in purulent processes of the cornea in an advanced stage. Collection of articles: Modern methods of diagnosis and treatment of diseases of the cornea and sclera. 2007:168-173. (In Russ.)
  6. Kovalevskaya M, Sergeeva M, Chernikova I, Nyrkova E. Methods of medicamentous correction of a condition the ocular surface in viral diseases of the eye. Lechashchii vrach. 2012;10:103-106. (In Russ.)
  7. Shaimova V. Clinico-etiologic features of various types of courses of suppurative corneal ulcer. Vestnik oftal’mologii. 2002;118(1):39-41. (In Russ.)
  8. Kononenko L, Maichuk Yu, Yuzhakov A. Federal clinical recommendations - clinical picture, diagnosis and conservative therapy of bacterial corneal ulcers. http://semashkorzn.ru/files/1a8a1b7e1112a2bbc45fe7965dbc79b3.pdf. (In Russ.)
  9. Kasparov A., Sadykhov A, Malozhen S. Treatment of purulent corneal ulcers. Vestnik oftal’mologii. 1987;103(6):67-71. (In Russ.)
  10. Krachmer JH, Mannis MJ, Holland EJ. Fundamentals, diagnosis and management. Cornea, Vol 2. Elsevier Mosby; 2005:1005-1033.
  11. McCulley JP, Dougherty JM. Blepharitis associated with acne rosacea and seborrheic dermatitis. Int Ophthalmol Clin. 1985;25(1):159-172. doi:10.1097/00004397-198502510-00010
  12. Pinna A et al. Identification and antibiotic susceptibility of coagulase negative staphylococci isolated in corneal/external infections. Br J Ophthalmol. 1999;83(7):771-773. doi:10.1136/bjo.83.7.771
  13. Marquart ME, O’Callaghan RJ. Infectious keratitis: secreted bacterial proteins that mediate corneal damage. J Ophthalmol. 2013;2013:369094. doi:10.1155/2013/369094
  14. Rosenfeld SI et al. Granular epithelial keratopathy as an unusual manifestation of Pseudomonas keratitis associated with extended-wear soft contact lenses. Am J Ophthalmol. 1990;109(1):17-22. doi:10.1016/s0002-9394(14)75572-2
  15. McLeod SD. Nonulcerating bacterial keratitis associated with soft and rigid contact lens wear. Ophthalmology. 1998;105(3):517-521. doi:10.1016/s0161-6420(98)93036-6
  16. Lee JS et al. Gonococcal keratoconjunctivitis in adults. Eye (Lond). 2002;16(5):646-649. doi:10.1038/sj.eye.6700112
  17. Ullman S, Roussel TJ, Forster RK. Gonococcal keratoconjunctivitis. Surv Ophthalmol. 1987;32(3):199-208. doi:10.1016/0039-6257(87)90095-6
  18. Matoba AY et al. Infectious crystalline keratopathy due to Streptococcus pneumoniae. Possible association with serotype. Ophthalmology. 1994;101(6):1000-1004. doi:10.1016/s0161-6420(94)31229-2
  19. Lin JC et al. Treatment of Nocardia asteroides keratitis with polyhexamethylene biguanide. Ophthalmology. 1997;104(8):1306-1311. doi:10.1016/s0161-6420(97)30143-2
  20. Sridhar MS et al. Treatment and outcome of nocardia keratitis. Cornea. 2001;20(5):458-462. doi:10.1097/00003226-200107000-00003
  21. Solomon A, Karp CL, Miller D, Dubovy SR, Huang AJ, Culbertson WW. Mycobacterium interface keratitis after laser in situ keratomileusis. Ophthalmology. 2001;108(12):2201-2208. doi:10.1016/s0161-6420(01)00851-x
  22. Karp CL, Tuli SS, Yoo SH, Vroman DT, Alfonso EC, Huang AH, Pflugfelder S.C., Culbertson W.W. Infectious keratitis after LASIK. Ophthalmology. 2003;110(3):503-510. doi:10.1016/S0161-6420(02)01760-8
  23. Daines BS et al. Rapid diagnosis and treatment of mycobacterial keratitis after laser in situ keratomileusis. J Cataract Refract Surg. 2003;29(5):1014-1018. doi:10.1016/s0886-3350(02)01613-9
  24. O’Day DM et al. The problem of bacillus species infection with special emphasis on the virulence of Bacillus cereus. Ophthalmology. 1981;88(8):833-838. doi:10.1016/s0161-6420(81)34960-4
  25. Choudhuri KK et al. Clinical and microbiological profile of Bacillus keratitis. Cornea. 2000;19(3):301-306. doi:10.1097/00003226-200005000-00009
  26. http://www.rusmedserv.com/mycology/html/eye.htm#2
  27. Thomas PA. Fungal infections of the cornea. Eye. 2003;17(8):852-862. doi:10.1038/sj.eye.6700557
  28. Alfonso E, Rosa RJ, Miller D. Fungal keratitis. In: Krachmer JH, Mannis MJ, Holland EJ. Cornea. 2nd Ed Elsevier. Mosby. 2005;1(86):1101-1111.
  29. Berger ST, Katsev DA, Mondino BJ, Pettit TH. Macroscopic Pigmentation in a Dematiaceous Fungal Keratitis Cornea. 1991;10(3):272-276. doi:10.1097/00003226-199105000-00014
  30. Gimranov P, Mal'khanov V. Associated Herpesvirus-bacterial infection of the organ of vision. Vestnik oftal’mologii. 1988;2:68-69. (In Russ.)
  31. Kasparov A. Оphthalmoherpes. Meditsina; 1994:106-108. (In Russ.)
  32. Maichuk Yu. Viral diseases of the eye. M.: Meditsina; 1981. (In Russ.)
  33. Avetisov S, Gordeeva L, Grigoryan M. Acanthamoeba lesions of the cornea. Vestnik oftal’mologii. 2001;117(5):53-56. (In Russ.)
  34. Okolov I, Kargal'tseva N, Naumenko V, Nikulin S et al. Acanthamoeba and Acanthamoeba keratitis. Manual for doctors. Balashevich L, ed. 2005. (In Russ.)
  35. Kaufman HE, Barron BA, McDonald MB. Parasitic infections. The Cornea 2-nd Edition. Butterworth-Heinemann; 1998:333.
  36. Ahn M, Yoon K-C, Ryu S-K, Cho N-C, You I-C. Clinical aspects and prognosis of mixed microbial (bacterial and fungal) keratitis. Cornea. 2011;30(4):409-413. doi:10.1097/ico.0b013e3181f23704
  37. Hong J, Ji J, Xu J, Cao W, Liu Z, Sun X. An unusual case of Acanthamoeba Polyphaga and Pseudomonas Aeruginosa keratitis. Diagn Pathol. 2014.;9:105. doi:10.1186/1746-1596-9-105
  38. Baum J, Barza M. The evolution of antibiotic therapy for bacterial conjunctivitis and keratitis: 1970-2000. Cornea. 2000;19(5):659-672. doi:10.1097/00003226-200009000-00011
  39. Okolov I, Kaftyreva L. The resistance to antibiotics of coagulase-negative staphylococci isolated from patients with conjunctivitis. Novoe v oftal'mologii. 2006;4:34-36. (In Russ.)
  40. Sueke H, Shankar J, Neal TJ, Horsburgh M, Gilbert R, Kaye SB. New Developments in Antibacterial Chemotherapy for Bacterial Keratitis. В: Reinhard T, Larkin F, eds. Corneal Disease. Springer Berlin Heidelberg; 2013:19-35. doi:10.1007/978-3-642-28747-3_2
  41. Galeeva G, Samoĭlov A, Rascheskov A. On the importance of multidrug-resistant strains of pathogenic microorganisms in ophthalmic practice Vestnik Oftal’mologii. 2015;131(2):110-114. (In Russ.)
  42. Allan BD, Morlet N, Dart JK. Microbiologic investigation of suspected microbial keratitis. Ophthalmology. 1996;103(8):1165-1166. doi:10.1016/s0161-6420(96)30528-9
  43. Levey SB, Katz HR, Abrams DA, Hirschbein MJ, Marsh MJ. The role of cultures in the management of ulcerative keratitis. Cornea. 1997;16(4):383-386. doi:10.1097/00003226-199707000-00002
  44. McLeod SD, Kolahdouz-Isfahani A, Rostamian K, Flowers CW, Lee PP, McDonnell PJ. The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis. Ophthalmology. 1996;103(1):23-28. doi:10.1016/s0161-6420(96)30738-0
  45. Rodman RC, Spisak S, Sugar A, Meyer RF, Soong HK, Musch DC. The utility of culturing corneal ulcers in a tertiary referral center versus a general ophthalmology clinic. Ophthalmology. 1997;104(11):1897-1901. doi:10.1016/s0161-6420(97)30010-4
  46. McDonnell PJ, Nobe J, Gauderman WJ, Lee P, Aiello A, Trousdale M. Community care of corneal ulcers. Am J Ophthalmol. 1992;114(5):531-538. doi:10.1016/s0002-9394(14)74479-4
  47. Jones DB. Initial therapy of suspected microbial corneal ulcers. II. Specific antibiotic therapy based on corneal smears. Surv Ophthalmol. 1979;24(2):97,105-116. doi:10.1016/0039-6257(79)90128-0
  48. Groden LR, Rodnite J, Brinser JH, Genvert GI. Acridine orange and Gram stains in infectious keratitis. Cornea. 1990;9(2):122-124. doi:10.1097/00003226-199004000-00007
  49. Cavanagh HD, El-Agha MS, Petroll WM, Jester JV. Specular microscopy, confocal microscopy, and ultrasound biomicroscopy: diagnostic tools of the past quarter century. Cornea. 2000.;19(5):712-722. doi:10.1097/00003226-200009000-00016
  50. Forster RK. Conrad Berens Lecture. The management of infectious keratitis as we approach the 21st century. CLAO J. 1998;24(3):175-180.
  51. Kovalevskaya M, Maichuk D, Brzheskii V, Okolov I. Syndrome of «red eye»: Pract. Guide for ophthalmologists. Edited by Maichuk D. Moskow; 2010. (In Russ.)
  52. Ayaki M, Iwasawa A, Soda M, Yaguchi S, Koide R. Cytotoxicity of five fluoroquinolone and two nonsteroidal anti-inflammatory benzalkonium chloride-free ophthalmic solutions in four corneoconjunctival cell lines. Clin Ophthalmol. 2010;4:1019-1024. doi:10.2147/opth.s12452
  53. Bezwada P, Clark LA, Schneider S. Intrinsic cytotoxic effects of fluoroquinolones on human corneal keratocytes and endothelial cells. Curr Med Res Opin. 2008;24(2):419-424. doi:10.1185/030079908x261005
  54. Park SH, Lim J-A, Choi J-S, Kim K-A, Joo C-K. The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics. Cornea. 2009;28(1):68-72. doi:10.1097/ico.0b013e318182259b
  55. Keating GM. Moxifloxacin 0.5% ophthalmic solution: in bacterial conjunctivitis. Drugs. 2011;71(1):89-99. doi:10.2165/11205840-000000000-00000
  56. Vignesh AP, Srinivasan R, Karanth S. A Case Report of Severe Corneal Toxicity following 0.5% Topical Moxifloxacin Use. Case Rep Ophthalmol. 2015;6(1):63-65. doi:10.1159/000376606
  57. Benitez-Del-Castillo J, Verboven Y, Stroman D, Kodjikian L. The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis. Clin Drug Investig. 2011;31(8):543-557. doi:10.2165/11589020-000000000-00000
  58. Sueke H, Kaye SB, Neal T, Hall A, Tuft S, Parry CM. An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis. Invest Ophthalmol Vis Sci. 2010;51(8):4151-4155. doi:10.1167/iovs.09-4839
  59. Pankey GA. Tigecycline. J Antimicrob Chemother. 2005;56(3):470-480. doi:10.1093/jac/dki248
  60. Ay GM, Akhan SC, Erturk S, Aktas ES, Ozkara SK, Caglar Y. Comparison of intravitreal ceftazidime and meropenem in treatment of experimental pseudomonal posttraumatic endophthalmitis in a rabbit model. J Appl Res. 2004;4:336-345.
  61. Moellering RC. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med. 2003;138(2):135-142. doi:10.7326/0003-4819-138-2-200301210-00015
  62. Hanet M-S, Jamart J, Chaves AP. Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies. Can J Ophthalmol. 2012;47(6):493-499. doi:10.1016/j.jcjo.2012.09.001
  63. Kanski JJ, Bowling B. Clinical Ophthalmology: A Systematic Approach. Elsevier Health Sciences; 2011.
  64. Moellering RC, Wennersten C, Weinstein AJ. Penicillin-tobramycin synergism against enterococci: a comparison with penicillin and gentamicin. Antimicrob Agents Chemother. 1973;3(4):526-529. doi:10.1128/aac.3.4.526
  65. Friedland IR, Klugman KP. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet. 1992;339(8790):405-408. doi:10.1016/0140-6736(92)90087-j
  66. McLeod SD, LaBree LD, Tayyanipour R, Flowers CW, Lee PP, McDonnell PJ. The importance of initial management in the treatment of severe infectious corneal ulcers. Ophthalmology. 1995;102(12):1943-1948. doi:10.1016/s0161-6420(95)30771-3
  67. Chiquet C, Romanet J-P. Prescribing fortified eye drops. J Fr Ophtalmol. 2007;30(4):423-430.
  68. Kugleev A, Zamyslova T, Voevodina I. Use of immobilized collagenase-collapor in the treatment of eye diseases Vestnik Oftal’mologii. 1995;111(1):14-16. (In Russ.)
  69. Kearns VR, Williams RL. Drug delivery systems for the eye. Expert Rev Med Devices. 2009;6(3):277-290.
  70. Behar-Cohen F. Drug delivery systems to target the anterior segment of the eye: fundamental bases and clinical applications. J Fr Ophtalmol. 2002;25(5):537-544.
  71. Luchs JI, Nelinson DS, Macy JI, LAC-07-01 Study Group. Efficacy of hydroxypropyl cellulose ophthalmic inserts (LACRISERT) in subsets of patients with dry eye syndrome: findings from a patient registry. Cornea. 2010;29(12):1417-1427. doi:10.1097/ico.0b013e3181e3f05b
  72. Boiko Е, Danilichev V, Pavlyuchenko V, Fokina D, Reituzov V, Alekperov S, Dolgikh V. Hydrogel therapeutic soft contact lenses penetrared by fluoroquinolones. Sovremennaya optometriya. 2011;4:6-18. (In Russ.)
  73. Garg P, Sharma S, Rao GN. Ciprofloxacin-resistant Pseudomonas keratitis. Ophthalmology. 1999;106(7):1319-1323.
  74. Borkar DS, Acharya NR, Leong C, Lalitha P, Srinivasan M, Oldenburg CE, Cevallos V, Lietman TM, Evans DJ, Fleiszig SMJ. Cytotoxic clinical isolates of Pseudomonas aeruginosa identified during the Steroids for Corneal Ulcers Trial show elevated resistance to fluoroquinolones. BMC Ophthalmol. 2014;14:54. doi:10.1186/1471-2415-14-54
  75. Bourkiza R, Kaye S, Bunce C, Shankar J, Neal T, Tuft S. Initial treatment of Pseudomonas aeruginosa contact lens-associated keratitis with topical chloramphenicol, and effect on outcome. Br J Ophthalmol. 2013;97(4):429-432. doi:10.1136/bjophthalmol-2012-302251
  76. Jain S, Azar DT. Eye infections after refractive keratotomy. J Refract Surg. 1996;12(1):148-155.
  77. Tajima K, Miyake T, Koike N, Hattori T, Kumakura S, Yamaguchi T, Matsumoto T., Fujita K., Kuroda M., Ito N., Goto H. In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis. J Infect Chemother. 2014;20(6):343-349. doi:10.1016/j.jiac.2013.10.015
  78. McElnea E, Stapleton P, Khan S, Stokes J, Higgins G. Challenges in the management of Neisseria gonorrhoeae keratitis. Int Ophthalmol. 2014;35(1):135-140. doi:10.1007/s10792-014-0032-8
  79. Kestelyn P, Bogaerts J, Stevens AM, Piot P, Meheus A. Treatment of adult gonococcal keratoconjunctivitis with oral norfloxacin. Am J Ophthalmol. 1989;108(5):516-523. doi:10.1016/0002-9394(89)90427-3
  80. Ermakov M. On the application Sulfidine with festering ulcers of the cornea, and dacryocystitis. Vestnik Ofta’lmologii. 1941;19(11-12):21-24. (In Russ.)
  81. Gol'denberg, A. Treatment of creeping and other festering ulcers of cornea by Albucidum. Vestnik Oftal’mologii. 1943;22(1):34-38. (In Russ.)
  82. Egorov V, Smoliakova G, Sorokin E, Abdullin I. Experimental study of the efficiency of use of sodium hypochlorite in the complex treatment of purulent keratitis Vestnik Oftal’mologii. 2005;121(6):43-45. (In Russ.)
  83. Santos TMA, Ledbetter EC, Caixeta LS, Bicalho MLS, Bicalho RC. Isolation and characterization of two bacteriophages with strong in vitro antimicrobial activity against Pseudomonas aeruginosa isolated from dogs with ocular infections. Am J Vet Res. 2011;72(8):1079-1086. doi:10.2460/ajvr.72.8.1079
  84. Zapuskalov I, Krivosheina O, Yelegecheva O. Use of autologous blood mononuclear cells in the complex treatment of corneal ulcers. Vestnik Oftal’mologii. 2008;124(5):32-35. (In Russ.)
  85. Wilhelmus KR. Indecision about corticosteroids for bacterial keratitis: an evidence-based update. Ophthalmology. 2002;109(5):835-842;quiz 843. doi:10.1016/s0161-6420(02)00963-6
  86. Miedziak AI, Miller MR, Rapuano CJ, Laibson PR, Cohen EJ. Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology. 1999;106(6):1166-1170;discussion 1171. doi:10.1016/s0161-6420(99)90250-6
  87. Herretes S, Wang X, Reyes JMG. Topical corticosteroids as adjunctive therapy for bacterial keratitis. Cochrane Database Syst Rev. 2014;10:CD005430.
  88. Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, O’Brien KS, Glidden DV, Ray KJ, Oldenburg CE, Zegans ME, Whitcher JP, McLeod SD, Porco TC, Lietman TM, Acharya NR. The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial. Am J Ophthalmol. 2014;157(2):327-333.e3. doi:10.1016/j.ajo.2013.09.025
  89. Livingstone I, Stefanowicz F, Moggach S, Connolly J, Ramamurthi S, Mantry S, и др. New insight into non-healing corneal ulcers: iatrogenic crystals. Eye (Lond). 2013;27(6):755-762. doi:10.1038/eye.2013.39
  90. Wood TO, Williford W. Treatmen of keratomycosis with amphotericin B 0.15%. Am J Ophthalmol. 1976;81(6):847-849. doi:10.1016/0002-9394(76)90369-x
  91. Mselle J. Use of topical clotrimazole in human keratomycosis. Ophthalmologica. 2001;215(5):357-360. doi:10.1159/000050885
  92. Somova V, Novickaja I. Oftal'momikozy: est' ili net? Tezisy X Sezda oftal'mologov Rossii. Sbornik nauchnyh materialov. M.; 2015:63. (In Russ.)
  93. Shah KB, Wu TG, Wilhelmus KR, Jones DB. Activity of voriconazole against corneal isolates of Scedosporium apiospermum. Cornea. 2003;22(1):33-36. doi:10.1097/00003226-200301000-00008
  94. Panda A, Ahuja R, Biswas NR, Satpathy G, Khokhar S. Role of 0.02% polyhexamethylene biguanide and 1% povidone iodine in experimental Aspergillus keratitis. Cornea. 2003;22(2):138-141. doi:10.1097/00003226-200303000-00012
  95. Rahman MR, Johnson GJ, Husain R, Howlader SA, Minassian DC. Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh. Br J Ophthalmol. 1998;82(8):919-925. doi:10.1136/bjo.82.8.919
  96. O’Day DM, Ray WA, Head WS, Robinson RD. Influence of the corneal epithelium on the efficacy of topical antifungal agents. Invest Ophthalmol Vis Sci. 1984;25(7):855-859.
  97. O’Day DM. Orally administered antifungal therapy for experimental keratomycosis. Trans Am Ophthalmol Soc. 1990;88:685-725.
  98. Maĭchuk Iu. Therapeutic algorithms in infectious ulcers of cornea. Vestnik Oftal’mologii. 2000;116(3):35-37. (In Russ.)
  99. Stern GA, Buttross M. Use of corticosteroids in combination with antimicrobial drugs in the treatment of infectious corneal disease. Ophthalmology. 1991;98(6):847-853. doi:10.1016/s0161-6420(91)32211-5
  100. Schreiber W, Olbrisch A, Vorwerk CK, König W, Behrens-Baumann W. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis. Invest Ophthalmol Vis Sci. 2003;44(6):2634-2643. doi:10.1167/iovs.02-1135
  101. Foster RK. The role of excisional keratoplasty in microbial keratitis. In: Cavanagh HD, ed. The Cornea. Transactions of the World Congress on the Cornea III, New York, 1988, Raven Press.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.